BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17851794)

  • 21. Surgery as a bridge to palliative chemotherapy in patients with malignant bowel obstruction from colorectal cancer.
    Helyer LK; Law CH; Butler M; Last LD; Smith AJ; Wright FC
    Ann Surg Oncol; 2007 Apr; 14(4):1264-71. PubMed ID: 17235711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes and treatment outcome of mechanical bowel obstruction in north eastern Nigeria.
    Madziga AG; Nuhu AI
    West Afr J Med; 2008 Apr; 27(2):101-5. PubMed ID: 19025024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of somatostatin combined with oral vancomycin in the treatment of intestinal obstruction after liver transplantation].
    Cai CJ; Li MR; Yi SH; Wang GS; Lu MQ; Chen GH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):335-8. PubMed ID: 18636354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific oral medications decrease the need for surgery in adhesive partial small-bowel obstruction.
    Chen SC; Lee CC; Yen ZS; Lin GS; Chen WJ; Lee PH; Lai HS; Lin FY; Chen WJ
    Surgery; 2006 Mar; 139(3):312-6. PubMed ID: 16546494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open trial of octreotide long-acting release in the management of short bowel syndrome.
    Nehra V; Camilleri M; Burton D; Oenning L; Kelly DG
    Am J Gastroenterol; 2001 May; 96(5):1494-8. PubMed ID: 11374688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of oral Gastrografin in adhesive, partial small-bowel obstruction: a prospective randomized trial.
    Assalia A; Schein M; Kopelman D; Hirshberg A; Hashmonai M
    Surgery; 1994 Apr; 115(4):433-7. PubMed ID: 8165534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive pharmacological treatment for reversing malignant bowel obstruction.
    Mercadante S; Ferrera P; Villari P; Marrazzo A
    J Pain Symptom Manage; 2004 Oct; 28(4):412-6. PubMed ID: 15471659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical application of self-expandable metallic stent for treatment of colorectal obstruction caused by extrinsic invasive tumors.
    Shin SJ; Kim TI; Kim BC; Lee YC; Song SY; Kim WH
    Dis Colon Rectum; 2008 May; 51(5):578-83. PubMed ID: 18259816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practice Patterns of Medications for Patients With Malignant Bowel Obstruction Using a Nationwide Claims Database and the Association Between Treatment Outcomes and Concomitant Use of H
    Minoura T; Takeuchi M; Morita T; Kawakami K
    J Pain Symptom Manage; 2018 Feb; 55(2):413-419.e2. PubMed ID: 29122616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management and prognosis of advanced ovarian cancer associated with bowel metastasis and obstruction].
    Wu M; Lang J; Huang R
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):617-20. PubMed ID: 9275459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases.
    Perlemuter G; Cacoub P; Chaussade S; Wechsler B; Couturier D; Piette JC
    Arthritis Rheum; 1999 Jul; 42(7):1545-9. PubMed ID: 10403284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sandostatin as a "hormonal" temporary protective ileostomy in patients with total or subtotal colectomy.
    Spiliotis J; Tambasis E; Christopoulou A; Rogdakis A; Siambaliotis A; Zografos K; Datsis A
    Hepatogastroenterology; 2003; 50(53):1367-9. PubMed ID: 14571739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliation of gastric outlet obstruction and proximal small bowel obstruction with self-expandable metal stents: a single center series.
    Mosler P; Mergener KD; Brandabur JJ; Schembre DB; Kozarek RA
    J Clin Gastroenterol; 2005 Feb; 39(2):124-8. PubMed ID: 15681907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
    Kehoe SM; Williams NL; Yakubu R; Levine DA; Chi DS; Sabbatini PJ; Aghajanian CA; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2009 May; 113(2):228-32. PubMed ID: 19254808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Octreotide acetate-steroid combination therapy for malignant gastrointestinal obstruction.
    Murakami H; Matsumoto H; Nakamura M; Hirai T; Yamaguchi Y
    Anticancer Res; 2013 Dec; 33(12):5557-60. PubMed ID: 24324097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center.
    Laval G; Arvieux C; Stefani L; Villard ML; Mestrallet JP; Cardin N
    J Pain Symptom Manage; 2006 Jun; 31(6):502-12. PubMed ID: 16793490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effects of long-term sedation on intestinal function].
    Zielmann S; Grote R
    Anaesthesist; 1995 Dec; 44 Suppl 3():S549-58. PubMed ID: 8592966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical approaches to malignant bowel obstruction.
    Helyer L; Easson AM
    J Support Oncol; 2008 Mar; 6(3):105-13. PubMed ID: 18402300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic therapy for malignant bowel obstruction.
    Frech EJ; Adler DG
    J Support Oncol; 2007; 5(7):303-10, 319. PubMed ID: 17708120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined arterial infusion and stent implantation compared with metal stent alone in treatment of malignant gastroduodenal obstruction.
    Wang Z; Chen K; Gong J; Zheng Y; Wang T
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1011-8. PubMed ID: 19669831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.